Published on in Vol 11 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40373, first published
.
Journals
- Hijazi B, Shi H, Liu S, Wei T, Alqurashi T, Sabri Z, Singh V, Hamdy H. Safety and efficacy of prostatic artery embolization in patients with hematuria due to benign prostate hyperplasia. African Journal of Urology 2023;29(1) View
- Zhang Y, Zhong X, Shao Y, Gong J. Insula Connectivity Abnormalities Predict Impulsivity in Chronic Heroin Use Disorder: A Cross-Sectional Resting-State fMRI Study. Brain Sciences 2023;13(11):1508 View
- Li S, Zhang D, Liu J, Su H, Guo L, Wu Q, Du J, Jiang H, Zhong N, Huang C, Chen T, Zhao M. The preliminary efficacy of virtual agent-assisted intelligent rehabilitation treatment (Echo app v2.0) in patients with alcohol use disorders: Study protocol for a randomized controlled trial. DIGITAL HEALTH 2023;9 View
- Li S, Wang Y, Chen L, Chen T, Du J, Su H, Jiang H, Wu Q, Zhang L, Bao J, Zhao M. Virtual agents among participants with methamphetamine use disorders: Acceptability and usability study. Journal of Telemedicine and Telecare 2024 View
- Liu W, Liu L, Deng Z, Liu R, Ma T, Xin Y, Xie Y, Zhou Y, Tang Y. Associations between impulsivity and fecal microbiota in individuals abstaining from methamphetamine. CNS Neuroscience & Therapeutics 2024;30(2) View
- Laymouna M, Ma Y, Lessard D, Schuster T, Engler K, Lebouché B. Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review. Journal of Medical Internet Research 2024;26:e56930 View
- Lee S, Yoon J, Cho Y, Chun J. A systematic review of chatbot-assisted interventions for substance use. Frontiers in Psychiatry 2024;15 View
- Uetova E, Hederman L, Ross R, O’Sullivan D. Exploring the characteristics of conversational agents in chronic disease management interventions: A scoping review. DIGITAL HEALTH 2024;10 View